Cargando…
Clinically- versus serologically-identified varicella: A hidden infection burden. A ten-year follow-up from a randomized study in varicella-endemic countries
Varicella-zoster virus (VZV) infections cause a substantial disease burden, which is underestimated due to incomplete reporting data and lack of serological surveillance. In this post-hoc analysis of a randomized, Phase IIIb clinical trial (NCT00226499) with a ten-year follow-up period, we report an...
Autores principales: | Gillard, Paul, Povey, Michael, Carryn, Stephane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437481/ https://www.ncbi.nlm.nih.gov/pubmed/34181506 http://dx.doi.org/10.1080/21645515.2021.1932217 |
Ejemplares similares
-
2355. Clinically vs. Serologically Identified Varicella: A Hidden Infection Burden. Lessons of 10-Year Follow-up in Varicella Endemic Countries
por: Gillard, Paul, et al.
Publicado: (2018) -
No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination
por: Carryn, Stephane, et al.
Publicado: (2021) -
Economic burden of varicella in Europe in the absence of universal varicella vaccination
por: Pawaskar, Manjiri, et al.
Publicado: (2021) -
The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019) -
Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial
por: Prymula, Roman, et al.
Publicado: (2016)